Literature DB >> 1570851

Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.

J Parasrampuria1, L C Li, A H Stelmach, T R Sykes, G A Gordon.   

Abstract

The stability of ganciclovir 1 and 5 mg/mL in 5% dextrose injection and in 0.9% sodium chloride injection was studied at 25 degrees C and 5 degrees C over 35 days. Ganciclovir (as the sodium salt) was added to 120 polyvinyl chloride bags containing either 5% dextrose injection or 0.9% sodium chloride injection to attain ganciclovir concentrations of 1 and 5 mg/mL. Thirty bags were prepared for each combination of drug concentration and i.v. solution. Half of the bags in each group were stored at 25 degrees C; the other half were stored at 5 degrees C. Samples withdrawn from all 120 bags immediately after preparation were frozen for later determination of initial concentration. At 7, 14, 21, 28, and 35 days after preparation, approximately 5-mL samples representing each test condition were withdrawn for analysis. The samples were visually examined, tested for pH, and assayed by high-performance liquid chromatography. There was no significant loss of ganciclovir under any of the study conditions over 35 days. All solutions were clear throughout the study period. The pH decreased slightly in both diluents at both ganciclovir concentrations but did not deviate from the manufacturer's range (9-11). Admixtures containing ganciclovir 1 and 5 mg/mL (as the sodium salt) in 5% dextrose injection and 0.9% sodium chloride injection were stable in polyvinyl chloride bags stored at 25 degrees C and 5 degrees C for 35 days.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570851

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  3 in total

1.  Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.

Authors:  Irene Krämer; Matteo Federici
Journal:  Eur J Hosp Pharm       Date:  2018-11-26

2.  Cytomegalovirus Retinitis Screening and Treatment in Human Immunodeficiency Virus Patients in Malawi: A Feasibility Study.

Authors:  Paulina Ocieczek; James R Barnacle; Joe Gumulira; Sam Phiri; Tom Heller; Iwona Grabska-Liberek
Journal:  Open Forum Infect Dis       Date:  2019-11-06       Impact factor: 3.835

Review 3.  Management of cytomegalovirus corneal endotheliitis.

Authors:  Angela H Y Wong; Wee Nie Kua; Alvin L Young; Kelvin H Wan
Journal:  Eye Vis (Lond)       Date:  2021-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.